This federal contract award, valued at $61,407.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication, with a completion date of December 23, 2024.
The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This contract award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen's extensive federal contract portfolio demonstrates its role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 3/23/25, 12:48 AM